Cargando…
MBCL-24. CAN YOUNG CHILDREN WITH RELAPSED MEDULLOBLASTOMA BE SALVAGED AFTER INITIAL IRRADIATION-SPARING APPROACHES?
INTRODUCTION: Irradiation-sparing approaches are used in young children with medulloblastoma (MB) given the vulnerability of the developing brain to neurocognitive impairment. Limited data are available following relapse for these patients. We aimed to describe the management and outcomes of young c...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715107/ http://dx.doi.org/10.1093/neuonc/noaa222.500 |
_version_ | 1783618876679913472 |
---|---|
author | Erker, Craig Larouche, Valérie Margol, Ashley Cacciotti, Chantel Perreault, Sébastien Cohen, Kenneth J AbdelBaki, Mohamed S Hukin, Juliette Rassekh, Shahrad Rod Eisenstat, David D Wilson, Beverly Knipstein, Jeffrey Hoppmann, Anna L Sandler, Eric S Dorris, Kathleen Fay-McClymont, Taryn B Salloum, Ralph Harrod, Virginia L Crooks, Bruce Finlay, Jonathan L Bouffet, Eric Lafay-Cousin, Lucie |
author_facet | Erker, Craig Larouche, Valérie Margol, Ashley Cacciotti, Chantel Perreault, Sébastien Cohen, Kenneth J AbdelBaki, Mohamed S Hukin, Juliette Rassekh, Shahrad Rod Eisenstat, David D Wilson, Beverly Knipstein, Jeffrey Hoppmann, Anna L Sandler, Eric S Dorris, Kathleen Fay-McClymont, Taryn B Salloum, Ralph Harrod, Virginia L Crooks, Bruce Finlay, Jonathan L Bouffet, Eric Lafay-Cousin, Lucie |
author_sort | Erker, Craig |
collection | PubMed |
description | INTRODUCTION: Irradiation-sparing approaches are used in young children with medulloblastoma (MB) given the vulnerability of the developing brain to neurocognitive impairment. Limited data are available following relapse for these patients. We aimed to describe the management and outcomes of young children with MB who relapsed after initial treatment without craniospinal irradiation (CSI). METHODS: International retrospective study including patients with MB diagnosed between 1995–2017, ≤ 72 months old, initially treated without CSI, who subsequently relapsed. RESULTS: Data are available for 52 patients (32 male). Median age at initial diagnosis was 27 months (range, 6–72) with 24 being metastatic. Initial therapy included conventional chemotherapy alone or high-dose chemotherapy (HDC) in 21 and 31 subjects, respectively. Three received upfront focal irradiation. Molecular subgrouping, available for 24 tumors, included 9 SHH and 15 non-WNT/non-SHH. Median time to relapse was 13 months (range, 3–63). Relapse was local, disseminated or combined in 20, 15, and 16, respectively. Salvage therapy with curative intent was given in 42/52 patients, including CSI in 28 subjects (median dose 36Gy, 18–41.4) or focal irradiation in 5 others. Three received HDC only. At a median follow-up time of 46 months (range, 4–255), 25 (48%) were alive, including 7/9 SHH and 7/15 non-WNT/non-SHH. The 2- and 5-year OS was 67% and 56% (SE, 7%), respectively. Two of 3 patients with SHH who did not receive salvage radiotherapy are survivors. CONCLUSION: A substantial proportion of young children who relapse following irradiation-sparing strategies can be salvaged. Neurocognitive and ototoxicity outcomes are being evaluated. |
format | Online Article Text |
id | pubmed-7715107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77151072020-12-09 MBCL-24. CAN YOUNG CHILDREN WITH RELAPSED MEDULLOBLASTOMA BE SALVAGED AFTER INITIAL IRRADIATION-SPARING APPROACHES? Erker, Craig Larouche, Valérie Margol, Ashley Cacciotti, Chantel Perreault, Sébastien Cohen, Kenneth J AbdelBaki, Mohamed S Hukin, Juliette Rassekh, Shahrad Rod Eisenstat, David D Wilson, Beverly Knipstein, Jeffrey Hoppmann, Anna L Sandler, Eric S Dorris, Kathleen Fay-McClymont, Taryn B Salloum, Ralph Harrod, Virginia L Crooks, Bruce Finlay, Jonathan L Bouffet, Eric Lafay-Cousin, Lucie Neuro Oncol Medulloblastoma (Clinical) INTRODUCTION: Irradiation-sparing approaches are used in young children with medulloblastoma (MB) given the vulnerability of the developing brain to neurocognitive impairment. Limited data are available following relapse for these patients. We aimed to describe the management and outcomes of young children with MB who relapsed after initial treatment without craniospinal irradiation (CSI). METHODS: International retrospective study including patients with MB diagnosed between 1995–2017, ≤ 72 months old, initially treated without CSI, who subsequently relapsed. RESULTS: Data are available for 52 patients (32 male). Median age at initial diagnosis was 27 months (range, 6–72) with 24 being metastatic. Initial therapy included conventional chemotherapy alone or high-dose chemotherapy (HDC) in 21 and 31 subjects, respectively. Three received upfront focal irradiation. Molecular subgrouping, available for 24 tumors, included 9 SHH and 15 non-WNT/non-SHH. Median time to relapse was 13 months (range, 3–63). Relapse was local, disseminated or combined in 20, 15, and 16, respectively. Salvage therapy with curative intent was given in 42/52 patients, including CSI in 28 subjects (median dose 36Gy, 18–41.4) or focal irradiation in 5 others. Three received HDC only. At a median follow-up time of 46 months (range, 4–255), 25 (48%) were alive, including 7/9 SHH and 7/15 non-WNT/non-SHH. The 2- and 5-year OS was 67% and 56% (SE, 7%), respectively. Two of 3 patients with SHH who did not receive salvage radiotherapy are survivors. CONCLUSION: A substantial proportion of young children who relapse following irradiation-sparing strategies can be salvaged. Neurocognitive and ototoxicity outcomes are being evaluated. Oxford University Press 2020-12-04 /pmc/articles/PMC7715107/ http://dx.doi.org/10.1093/neuonc/noaa222.500 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Medulloblastoma (Clinical) Erker, Craig Larouche, Valérie Margol, Ashley Cacciotti, Chantel Perreault, Sébastien Cohen, Kenneth J AbdelBaki, Mohamed S Hukin, Juliette Rassekh, Shahrad Rod Eisenstat, David D Wilson, Beverly Knipstein, Jeffrey Hoppmann, Anna L Sandler, Eric S Dorris, Kathleen Fay-McClymont, Taryn B Salloum, Ralph Harrod, Virginia L Crooks, Bruce Finlay, Jonathan L Bouffet, Eric Lafay-Cousin, Lucie MBCL-24. CAN YOUNG CHILDREN WITH RELAPSED MEDULLOBLASTOMA BE SALVAGED AFTER INITIAL IRRADIATION-SPARING APPROACHES? |
title | MBCL-24. CAN YOUNG CHILDREN WITH RELAPSED MEDULLOBLASTOMA BE SALVAGED AFTER INITIAL IRRADIATION-SPARING APPROACHES? |
title_full | MBCL-24. CAN YOUNG CHILDREN WITH RELAPSED MEDULLOBLASTOMA BE SALVAGED AFTER INITIAL IRRADIATION-SPARING APPROACHES? |
title_fullStr | MBCL-24. CAN YOUNG CHILDREN WITH RELAPSED MEDULLOBLASTOMA BE SALVAGED AFTER INITIAL IRRADIATION-SPARING APPROACHES? |
title_full_unstemmed | MBCL-24. CAN YOUNG CHILDREN WITH RELAPSED MEDULLOBLASTOMA BE SALVAGED AFTER INITIAL IRRADIATION-SPARING APPROACHES? |
title_short | MBCL-24. CAN YOUNG CHILDREN WITH RELAPSED MEDULLOBLASTOMA BE SALVAGED AFTER INITIAL IRRADIATION-SPARING APPROACHES? |
title_sort | mbcl-24. can young children with relapsed medulloblastoma be salvaged after initial irradiation-sparing approaches? |
topic | Medulloblastoma (Clinical) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715107/ http://dx.doi.org/10.1093/neuonc/noaa222.500 |
work_keys_str_mv | AT erkercraig mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT larouchevalerie mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT margolashley mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT cacciottichantel mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT perreaultsebastien mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT cohenkennethj mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT abdelbakimohameds mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT hukinjuliette mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT rassekhshahradrod mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT eisenstatdavidd mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT wilsonbeverly mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT knipsteinjeffrey mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT hoppmannannal mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT sandlererics mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT dorriskathleen mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT faymcclymonttarynb mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT salloumralph mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT harrodvirginial mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT crooksbruce mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT finlayjonathanl mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT bouffeteric mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches AT lafaycousinlucie mbcl24canyoungchildrenwithrelapsedmedulloblastomabesalvagedafterinitialirradiationsparingapproaches |